WQ85347 (e) Wedi’i gyflwyno ar 31/05/2022

A yw Llywodraeth Cymru yn sicrhau bod meddyginiaethau clefydau prin ar gael yn y GIG cyn gynted ag y byddant yn cael awdurdodiad marchnata drwy gyfnod o fynediad wedi'i reoli?

Wedi'i ateb gan Y Gweinidog Iechyd a Gwasanaethau Cymdeithasol | Wedi'i ateb ar 09/06/2022

In Wales, decisions on the availability of medicines are guided by the advice of the National Institute for Health and Care Excellence (NICE) and the All Wales Medicines Strategy Group. 

The New Treatment Fund ensures medicines recommended by NICE and AWMSG are routinely available within 60 days of their first recommendation. This includes new and innovative medicines for all conditions, including those NICE recommend for use under managed access arrangements.  Since its launch 420 new treatments have been made available through the fund, with the average time to make a new medicine available in Wales just 15 days.